HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1ra) INCREASES SURVIVAL TIME IN PATIENTS WITH SEPSIS SYNDROME AND END ORGAN DYSFUNCTION (EOD)
- 1 January 1994
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 22 (1) , A193
- https://doi.org/10.1097/00003246-199401000-00369
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: